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The persistence of depression score
Spijker J, de Graaf R, Ormel J, Nolen WA, Grobbee DE, Burger H. The
persistence of depression score.
Objective: To construct a score that allows prediction of major
depressive episode (MDE) persistence in individuals with MDE using
determinants of persistence identiﬁed in previous research.
Method: Data were derived from 250 subjects from the general
population with new MDE according to DSM-III-R. These subjects
were recruited from the Netherlands Mental Health Survey and
Incidence Study (NEMESIS), using the Composite International
Diagnostic Interview. Determinants for persistence were transformed
into a practical risk score using proportional hazards models and
bootstrapping techniques.
Results: The risk of MDE persistence after 12 months was 23%. The
score comprised measures of physical illness, social support, depression
severity and recurrency, and duration of previous episodes. With
increasing categories of these measures, the predicted risks increased
from 7 to 40%.
Conclusion: We constructed the Persistence of Depression Score (PDS)
showing reasonable performance. The PDS could be of importance in
clinical practice to support treatment decisions.
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Significant outcomes
• The risk of persistence of major depressive episodes after 12 months is 23%.
• The persistence of depression score (PDS) is a clinical risk score to predict persistence of depression
with reasonable psychometric performance.
• The PDS can be applied with relative low burden to patient and budget.
Limitations
• Potential important genetic and biological predictors of persistence of depression were not assessed.
• The external validity and usefulness of the PDS needs to be studied further.
Introduction
Persistence of a major depressive episode (MDE) is
a common, and serious, clinical problem (1). If its
risk can be estimated accurately in single patients,
treatment may be individualized in the sense that
those with the highest risk receive most intense
treatment. However, setting a prognosis in indi-
vidual cases is diﬃcult. The prognostic skills of
clinicians are still underdeveloped and lack an
empirical basis (2). Although many studies of
depressed patients identiﬁed predictors of depres-
sion persistence, the analyses and presentation of
the results do not allow to predict the risk in an
individual patient (3–9).
In a recent paper based on results from a general
population survey [Netherlands Mental Health
Survey and Incidence Study (NEMESIS)], we
identiﬁed the following independent risk factors
for persistence of MDE: higher severity of the
index episode, longer duration of previous epi-
sodes, (chronic) physical illness and lack of social
support; a recurrent episode predicted earlier
recovery (10).
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Aims of the study
In the current paper, we will present a model how
to combine these determinants into a score that
enables a clinician to estimate the risk of persist-
ence of depression in individual subjects with
MDE.
Material and methods
NEMESIS is a prospective psychiatric epidemio-
logic survey in the Dutch adult general population
(aged 18–64 years) with three waves in 1996 (T0),
1997 (T1) and 1999 (T2). Methods are described in
detail elsewhere (10–14). Brieﬂy, NEMESIS is
based on a multistage, stratiﬁed, random sampling
procedure. In the ﬁrst wave, suﬃcient data were
gathered on 7076 persons, with a response rate of
69.7%. At T1, 1458 respondents (20.6%) were lost
to attrition and at T2, a further 822 (14.6%) were
lost leaving 4796 respondents that were interviewed
at all three waves. Psychopathology did not have a
strong impact on attrition: at T1 12-months ago-
raphobia (odds ratio (OR), 1.96) and social phobia
(OR, 1.37), and at T2 12-months major depression
(OR, 1.37), dysthymia (OR, 1.80) and alcohol
dependence (OR, 1.83), adjusted for demographic
factors, were associated with attrition (15).
Diagnoses of psychiatric disorders according to
DSM-III-R (16) were based on the Composite
International Diagnostic Interview (CIDI), Ver-
sion 1.1 (computerised version (17)). The CIDI is a
structured interview developed by the World
Health Organization (18), which has been found
to have acceptable interrater reliability and test–
retest reliability for most diagnoses, including
major depression (19). For our study cohort, we
included respondents with newly originated MDE
(ﬁrst or recurrent cases) between T1 and T2, that is
those with a diagnosis of 2-year prevalence of
major depression at T2 but no 1-month prevalence
of major depression diagnosis at T1 (n ¼ 250).
Individuals diagnosed with bipolar disorder or a
primary psychotic disorder were excluded. Dur-
ation of MDE was assessed with the Life Chart
Interview (20). A median duration of MDE of
3 months (95% CI 2.2–3.8 months) was found; for
nearly 20% of the depressed subjects duration of
the episode exceeded 24 months (13). A broad
range of potential determinants of persistence were
examined: age and gender, educational attainment,
cohabitation status, negative youth experiences,
neuroticism, previous psychiatric illnesses, physical
illness, life events and ongoing diﬃculties, social
support, and clinical characteristics as severity of
depression, the index episode being a ﬁrst or
recurrent episode, duration of previous episodes
and comorbidity with other DSM-III-R axis I
disorders [see Ref. 10 (10)].
Analyses
Cox proportional hazards models were used to
estimate the associations between the predictors
and recovery from MDE as published (10). For the
present study, the same ﬁnal Cox proportional
hazards model was ﬁtted on the same data. The
aim of the analysis was to calculate the cumulative
12-month risk of not having recovered, i.e. the risk
of depression persistence S(12 months) for each
patient. This appeared not straightforward as the
Cox regression procedure yields the actual survival
estimates [S(t)] only. These estimates represent the
predicted risks according to the model of depres-
sion persistence for each patient with his given
follow-up time and predictor values. They are
deﬁned as:
SðtÞ ¼ S0ðtÞexpðLPÞ
where the linear predictor (LP) is
b1*X1 + b2*X2 +   , with the X denoting the
predictor values and b the regression coeﬃcients.
The baseline survival function S0(t) is the time-
dependent cumulative risk of persistence of depres-
sion for a person with none of the predictors
present, i.e. the LP being zero and thus S0(t) ¼
[S(t)]. The baseline survival function [S0(t)] can be
calculated by remoulding the above formula as
follows:
S0ðtÞ ¼ SðtÞ1=expðLPÞ
This calculation allowed us to read the cumulative
12-month baseline risk from the database from
those patients who actually had 12 months of
follow-up [S0(12 months)]. In our study, this value
appeared to be 0.2029. The ﬁnal step was to
calculate the 12 month risk for all patients using
the S0(12 months) and the LP, the latter thus
representing the individual part of the risk. Hence,
Sð12monthsÞ ¼ S0ð12monthsÞexpðLPÞ
¼ S0ð0:2029ÞexpðLPÞ:
The 12-month time span was arbitrarily chosen,
not only primarily on clinical grounds but also
because at the time of follow-up the number of
patients at risk (of recovery) was still suﬃciently
large. To evaluate the calibration of the model, i.e.
to assess the extend to which the model predictions
are in agreement with the observed probabilities,
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we calculated the Kaplan–Meier estimate of the 12-
month risk of depression persistence for each decile
of predicted risk and compared them using a
scatter diagram (21).
As a next step, the discriminatory power of the
model was quantiﬁed. Because the outcomes of the
censored patients are unknown, the construction of
a receiver operating characteristic (ROC)-curve for
the evaluation of discriminatory power is imposs-
ible. However, the concordance statistic can still be
calculated (22). This statistic is numerically, and as
regards interpretation, equal to the area under the
ROC-curve. It is the probability that for a random
pair of patients the one who has the event ﬁrst has
the highest predicted probability. The concordance
statistic (or area under the ROC-curve) is an
overall measure of discriminatory power, with a
value 0.5 indicating no discrimination, and a value
1.0 indicating perfect discrimination between those
with and without the study outcome, i.e. depres-
sion persistence (23). Both the regression coeﬃ-
cients, and therefore also the hazard ratios with
their 95% conﬁdence intervals, as well as the
concordance-statistic, were adjusted for overﬁtting
or overoptimism using bootstrapping techniques
(24). To this end, 100 random bootstrap samples
with replacement were drawn from the dataset with
complete data on all predictors (n ¼ 250). The
model’s predictive performance after bootstrap-
ping is the performance that can be expected when
the model is applied to future similar populations
(25).
To construct a practically applicable persistence
of depression score (PDS), each coeﬃcient from the
model was transformed to a round number of
points. As the coeﬃcients reﬂect the relative weight
of each variable in the prediction, they were
transformed to a number of points in a uniform
way, i.e. each coeﬃcient was divided by the
coeﬃcient closest to zero, i.e. )0.107. The number
of points was subsequently rounded to the nearest
integer. The total score for each individual patient
was determined by assigning the points for each
variable present, and adding them up.
The predicted probability of persistence of
depression at 12 months follow-up was presented
according to four broad categories of the risk score
for reasons of statistical stability and practical
applicability. The categories were arbitrarily
chosen with a view to reasonable size as well as
clinical sensibility. Next, the score was transformed
to dichotomous prognostic tests allowing each
patient to be classiﬁed as high or low risk of
depression persistence. Sensitivity, speciﬁcity as
well as the positive and negative predictive value of
these tests were calculated for the same cut-oﬀs of
the PDS as those used to delineate the score
categories. The data were analysed using spss 12.0
and s-plus 2000 (SPSS Inc., Chicago, IL, USA).
Results
Characteristics of the study population are dis-
played in Table 1.
Follow-up time ranged from 0.5 to 24 months
and 187 subjects of the total population (n ¼ 250)
recovered. The ﬁnal proportional hazards regres-
sion model appeared reasonably calibrated as the
predicted and observed probabilities were similar
over the whole range (Fig. 1). The shrinkage factor
Table 1. Sociodemographic and clinical characteristics of a cohort (n ¼ 250) with
















Living with partner (yes) 63.6





Comorbid anxiety disorder 34.0














Fig. 1. Calibration plot of the Cox proportional hazards
model for the prediction of depression persistence at 12 months
of follow-up. The dotted line represents the line of identity, i.e.
perfect model calibration.
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for the coeﬃcients that was obtained from the
bootstrap process appeared 0.91. Models results
are presented after shrinkage. Coeﬃcients from the
model as well as the hazard ratios as measures of
relative risk are displayed in Table 2, together with
the risk points per predictor. The total risk score
was calculated using the formula at the bottom of
the table. For instance, a subject with a severe and
recurrent MDE, with a comorbid physical illness
and low social support, has a score of +3 ) 4 +
3 + 4 ¼ 6 points.
Table 3 shows the relationship between categ-
ories of the score, the observed risk and the
predicted risk of MDE persistence after 1 year.
The mean risk was 23% and the predicted risks
increased from 7 to 40% with increasing score
categories and were generally well in agreement
with the observed risk. From this table it can also
be seen that the subject introduced above has a
risk of 29% of persistence. The overall discrim-
inatory power of the score was fair with a
concordance statistic of 0.68. For speciﬁc cut-
oﬀs, the sensitivity, speciﬁcity and predictive
values are presented in Table 4. If, for instance,
a cut-oﬀ ‡5 is chosen as the threshold for more
intense treatment, 69% (sensitivity) of those who
would still suﬀer depression after 1 year will have
received this treatment as their prognostic test was
positive, i.e. high risk of persistence. Yet, 12%
(1)NPV) of those who did not have the more
intense treatment because their test was negative
will still have depression.
Discussion
In this paper, we extended our previous analysis of
risk factors for persistence of MDE in the general
population with the construction of the persistence
of depression score (PDS). Especially in general
practice, with a high prevalence of depressive
disorder, such a risk score could be of clear
importance in daily practice to support treatment
decisions (26, 27). For instance, in a patient with a
recently developed MDE and a low PDS score, a
policy of watchful waiting might be adopted, as the
natural course seems to be favourable. In a patient
with a high PDS score, however, immediate and
possibly more aggressive treatment is indicated
(28).
A strength of our study is that the elements of
the PDS can be assessed with relative low burden
to patient and budget. However, the discriminatory
power of the PDS is modest with a concordance
statistic of 0.68, in particular when compared with
concordance statistic or, equivalently, areas under
the curve of the ROC curve obtained in diagnostic
studies. But, it must be kept in mind that by nature
of the close temporal relation between predictors
and outcome, measures of discrimination generally
achieve higher values in the diagnostic than the
prognostic setting.
The concordance statistic is an overall measure
of model performance, i.e. independent of a certain
cut-oﬀ value for the predicted risk. In clinical
practice, however, a sensible cut-oﬀ value must be
chosen so that after the test, the probability of no
remission will be very high or low that it helps to
decide whether more intensive treatment (e.g. an
antidepressant in combination with psychother-
apy) is indicated. It must be kept in mind that false
negative patients in a prognostic test, i.e. patients




(95% confidence interval) Contribution to risk score
Physical illness )0.319 0.73 (0.54–0.97) 3
Medium social support )0.107 0.90 (0.64–1.27) 1
Low social support )0.420 0.66 (0.46–0.95) 4
Severe depression )0.314 0.73 (0.53–1.01) 3
Recurrent depression 0.392 1.48 (1.10–1.99) )4
Long duration previous episodes )0.426 0.65 (0.48–0.89) 4
Total risk score ¼ physical illness*3 + medium social support + low social support*4 + severe depres-
sion*3 ) recurrent depression*4 + long duration previous episodes*4












<2 66 (26) 60 (32) 6 (10) 8 7
2–4 75 (30) 61 (33) 14 (22) 17 18
5–7 60 (24) 40 (22) 20 (32) 29 29
‡8 49 (20) 26 (14) 23 (37) 46 40
Total 250 (100) 187 (100) 63 (100) 23 22
Table 4. Prognostic test characteristics for 12 month depression persistence
Cut-off score n (%) Sensitivity (%) Specificity (%) PPV (%) 1)NPV (%)
‡2 184 (74) 93 32 27 7
‡5 109 (44) 69 63 34 12
‡8 49 (20) 36 85 40 17
PPV, positive predictive value; NPV, negative predictive value.
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that incorrectly were withheld the appropriate
treatment will remain in treatment, so that treat-
ment adjustments can be made, albeit with some
time lag.
In NEMESIS we included individuals from the
general population with depressive episodes,
thereby avoiding referral ﬁlter bias. Some of these
individuals received treatment, in primary care or
in specialized mental health care (13). Depressed
individuals from the general population diﬀer from
selected depressed in-patients or out-patients (12)
and this could limit the utilization of the PDS in
speciﬁc treatment settings. However, the factors we
found to be associated with persistence, i.e. (chro-
nic) physical illness, lack of social support and
illness-related factors such as severity of the index
episode and prior episodes and their duration, were
very much in accordance with the literature and
this applies certainly for the illness-related factors
such as severity of the index episode and duration
of prior episodes (3–9). Furthermore, no diﬀerence
in duration of MDE was found in diﬀerential levels
of care (13).
A further strength of the study is that we used
bootstrapping techniques to correct for the inevit-
able problem of overoptimism of model perform-
ance in the derivation data, and consequently
poorer predictive accuracy in new patients. Boot-
strapping techniques have shown superiority over
other approaches to address these problems such
as split-sample or cross-validation methods (29).
However, demonstrating the external validity and
usefulness of this prediction score in the treatment
of depressed patients in future studies remains
indicated.
A limitation is that measurement error in the
assessment of the duration of MDE by interview
may have occurred and that as a result, some
short recurrent episodes may have been gone
undetected. Further, the predictors were analysed
as dichotomous variables which inevitably has
caused some loss of detail. However, a relatively
crude assessment reﬂects clinical practice and
therefore adds in our view to the generalizability
of the results. A further limitation may be that
NEMESIS did not include potentially important
genetic and other biological predictors of persis-
tence of MDE. Future research may yield biolo-
gical predictors of persistence, which may
improve our ability to forecast the course of
depression.
In conclusion, we were able to construct a
clinical risk score for the prediction of persistence
of MDE with reasonable performance. The PDS
may be of value to clinical practice in providing a
rational basis for treatment decisions.
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